Beirith et al. demonstrated that the inhibition of NK-1R by aprepitant achieves a significant reduction in the cell growth of pancreatic cancer cells, cancer stem cells, and pancreatic stellate cells in a dose-dependent manner. Here, TACR1 is linked to cancer.